Japan Results Roundup: Reduced Forex Impact, Uncertain US Tariff Outlook

But Most Mainstays Maintain Solid Growth

 
• By Lisa Takagi
  
Japan Q1 results
Mainstays lead fiscal Q1 growth at Japan's top pharma firms. (Shutterstock)
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Earnings

More from Japan